James P. Sheridan

Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

James P. Sheridan, Scot A. Marsters, Robert Pitti et al. · Science · 1997 · 1.7K citations

Signal Transduction, Signaling Pathway, G Protein-coupled Receptor +15

A novel receptor for Apo2L/TRAIL contains a truncated death domain

Scot A. Marsters, James P. Sheridan, Robert Pitti et al. · Current Biology · 1997 · 655 citations · Full text

Signal Transduction, Signaling Pathway, Truncated Death Domain +8

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta

Daniel Wynn, Michael D. Kaufman, Xavier Montalbán et al. · The Lancet Neurology · 2010 · 298 citations

Disease Progression, Medicine, Immunology +10

Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB

Scot A. Marsters, James P. Sheridan, Christopher J. Donahue et al. · Current Biology · 1996 · 250 citations · Full text

Inflammation, Cytokine, Signal Transduction +15

Identification of a ligand for the death-domain-containing receptor Apo3

Scot A. Marsters, James P. Sheridan, Robert Pitti et al. · Current Biology · 1998 · 185 citations · Full text

Signal Transduction, G Protein-coupled Receptor, Medicine +7